Correlation Between Cambricon Technologies and Shenzhen Bioeasy

Can any of the company-specific risk be diversified away by investing in both Cambricon Technologies and Shenzhen Bioeasy at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cambricon Technologies and Shenzhen Bioeasy into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cambricon Technologies Corp and Shenzhen Bioeasy Biotechnology, you can compare the effects of market volatilities on Cambricon Technologies and Shenzhen Bioeasy and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cambricon Technologies with a short position of Shenzhen Bioeasy. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cambricon Technologies and Shenzhen Bioeasy.

Diversification Opportunities for Cambricon Technologies and Shenzhen Bioeasy

0.92

Correlation Coefficient

Cambricon Technologies  Shenzhen Bioeasy

Almost no diversification

The 3 months correlation between Cambricon and Shenzhen is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Cambricon Technologies Corp and Shenzhen Bioeasy Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shenzhen Bioeasy Bio and Cambricon Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cambricon Technologies Corp are associated (or correlated) with Shenzhen Bioeasy. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shenzhen Bioeasy Bio has no effect on the direction of Cambricon Technologies i.e., Cambricon Technologies and Shenzhen Bioeasy go up and down completely randomly.

Pair Corralation between Cambricon Technologies and Shenzhen Bioeasy

Assuming the 90 days trading horizon Cambricon Technologies Corp is expected to generate 1.3 times more return on investment than Shenzhen Bioeasy. However, Cambricon Technologies is 1.3 times more volatile than Shenzhen Bioeasy Biotechnology. It trades about 0.24 of its potential returns per unit of risk. Shenzhen Bioeasy Biotechnology is currently generating about 0.17 per unit of risk. If you would invest  25,214  in Cambricon Technologies Corp on September 1, 2024 and sell it today you would earn a total of  30,886  from holding Cambricon Technologies Corp or generate 122.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	98.31%
Values	Daily Returns

Cambricon Technologies Corp  vs.  Shenzhen Bioeasy Biotechnology

Cambricon Technologies

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Cambricon Technologies Corp are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Cambricon Technologies sustained solid returns over the last few months and may actually be approaching a breakup point.

Shenzhen Bioeasy Bio

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Shenzhen Bioeasy Biotechnology are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shenzhen Bioeasy sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cambricon Technologies and Shenzhen Bioeasy

The main advantage of trading using opposite Cambricon Technologies and Shenzhen Bioeasy positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cambricon Technologies position performs unexpectedly, Shenzhen Bioeasy can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shenzhen Bioeasy will offset losses from the drop in Shenzhen Bioeasy's long position.

The idea behind Cambricon Technologies Corp and Shenzhen Bioeasy Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.